Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report

Burak Kulaksizoğlu,1,2 Hüseyin Kara,1,2 Berkan Bodur,1,2 Murat Kuloğlu1,2 1Department of Psychiatry, Akdeniz University School of Medicine, Antalya, Turkey; 2Akdeniz University, Alcohol and Substance Addiction Treatment and Research Center, Antalya, Turkey Abstract: Opioid misuse and depe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kulaksizoğlu B, Kara H, Bodur B, Kuloğlu M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/f769f021f0b94db78836eef0a12617b6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f769f021f0b94db78836eef0a12617b6
record_format dspace
spelling oai:doaj.org-article:f769f021f0b94db78836eef0a12617b62021-12-02T10:40:09ZIntravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report1178-2021https://doaj.org/article/f769f021f0b94db78836eef0a12617b62018-11-01T00:00:00Zhttps://www.dovepress.com/intravenous-buprenorphinenaloxone-and-concomitant-oral-pregabalin-misu-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Burak Kulaksizoğlu,1,2 Hüseyin Kara,1,2 Berkan Bodur,1,2 Murat Kuloğlu1,2 1Department of Psychiatry, Akdeniz University School of Medicine, Antalya, Turkey; 2Akdeniz University, Alcohol and Substance Addiction Treatment and Research Center, Antalya, Turkey Abstract: Opioid misuse and dependence are major medical and social concerns worldwide. Buprenorphine/naloxone combination (BNC) is a drug that has misuse potential and is used to treat opioid dependence, including buprenorphine and naloxone. Buprenorphine shows its pharmacological effects by binding to opioid receptors. Buprenorphine is a partial agonist and has smaller maximal effects compared to those of full agonists (heroin, methadone). Naloxone is a non-selective opiate antagonist added to buprenorphine for the prevention of intravenous diversion. BNC is used in the treatment of opioid dependence for detoxification and maintenance. The drug should be used as a sublingual film tablet. Pregabalin is used in the treatment of neuropathic pain, epilepsy and anxiety disorders. It is increasingly being reported as possessing a potential for misuse. In this article, we present a case of intravenous BNC and concomitant oral pregabalin misuse that developed in a monitored and treated patient for the reason of opioid dependence. Keywords: intravenous buprenorphine–naloxone, pregabalin, drug misuse, opioid addictionKulaksizoğlu BKara HBodur BKuloğlu MDove Medical Pressarticleintravenous buprenorphine-naloxonepregabalindrug misuseNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 14, Pp 3033-3035 (2018)
institution DOAJ
collection DOAJ
language EN
topic intravenous buprenorphine-naloxone
pregabalin
drug misuse
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle intravenous buprenorphine-naloxone
pregabalin
drug misuse
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Kulaksizoğlu B
Kara H
Bodur B
Kuloğlu M
Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
description Burak Kulaksizoğlu,1,2 Hüseyin Kara,1,2 Berkan Bodur,1,2 Murat Kuloğlu1,2 1Department of Psychiatry, Akdeniz University School of Medicine, Antalya, Turkey; 2Akdeniz University, Alcohol and Substance Addiction Treatment and Research Center, Antalya, Turkey Abstract: Opioid misuse and dependence are major medical and social concerns worldwide. Buprenorphine/naloxone combination (BNC) is a drug that has misuse potential and is used to treat opioid dependence, including buprenorphine and naloxone. Buprenorphine shows its pharmacological effects by binding to opioid receptors. Buprenorphine is a partial agonist and has smaller maximal effects compared to those of full agonists (heroin, methadone). Naloxone is a non-selective opiate antagonist added to buprenorphine for the prevention of intravenous diversion. BNC is used in the treatment of opioid dependence for detoxification and maintenance. The drug should be used as a sublingual film tablet. Pregabalin is used in the treatment of neuropathic pain, epilepsy and anxiety disorders. It is increasingly being reported as possessing a potential for misuse. In this article, we present a case of intravenous BNC and concomitant oral pregabalin misuse that developed in a monitored and treated patient for the reason of opioid dependence. Keywords: intravenous buprenorphine–naloxone, pregabalin, drug misuse, opioid addiction
format article
author Kulaksizoğlu B
Kara H
Bodur B
Kuloğlu M
author_facet Kulaksizoğlu B
Kara H
Bodur B
Kuloğlu M
author_sort Kulaksizoğlu B
title Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
title_short Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
title_full Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
title_fullStr Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
title_full_unstemmed Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
title_sort intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/f769f021f0b94db78836eef0a12617b6
work_keys_str_mv AT kulaksizoglub intravenousbuprenorphinenaloxoneandconcomitantoralpregabalinmisuseacasereport
AT karah intravenousbuprenorphinenaloxoneandconcomitantoralpregabalinmisuseacasereport
AT bodurb intravenousbuprenorphinenaloxoneandconcomitantoralpregabalinmisuseacasereport
AT kuloglum intravenousbuprenorphinenaloxoneandconcomitantoralpregabalinmisuseacasereport
_version_ 1718396922454081536